| > There are three noteworthy points arising from the report:
| >
[quoted text clipped - 12 lines]
| > disease which about 20 years earlier her doctors said would
| > shortly kill her.
| Go ehead if that's your wish.
What makes you think I have not?
I did not send this message to obtain
permission to take it from anyone,
least of all a "non-doc" like you.
I wrote it to show that laetrile is not
the dangerous quack remedy that it is
made out to be by certain dubious
characters on this news group.
| Of course the most important fact is that most of the posters here have
| the epithelial type of cancer (mother, daughter cells, wild tumors).
That is of no importance whatsoever.
Cancer is cancer is cancer.
| Different from (your) myeloma.
thank you, but I am already aware of that,
and so is everyone else,I believe.
| Suggest you discuss it on the ACOR myeloma mail list.
| J
Suggest away,I shall discuss it where I please.|
Old Bill
J - 30 Mar 2008 01:32 GMT
-------- Original Message --------
Date: Tue, 18 Dec 2007 20:30:28 -0000
From: "Old Bill" <matbeta@yahoo.com>
Organization: Datemas.de http://www.datemas.de
Newsgroups: alt.support.cancer
Here is a link to what Cancer Research Uk has to say about Laetrile.
http://tinyurl.com/2eenqg
[Excerpt]
Many internet sites advertise and promote laetrile as a treatment to cure
cancer. But no reputable scientific cancer organisations support any of
these claims. Our advice is to be very cautious about believing this type of
information or paying for any alternative cancer therapy over the internet.
Whenever we put up information on alternative treatments that have not been
properly tested, we receive angry emails that say we are trying to prevent
people with cancer from getting effective treatment. This is not what we want
to do. We are concerned that products are marketed as potential cures, and
often sold for a great deal of money, when they lack scientific evidence to
prove they help. It is not in the interests of drug companies or research
organisations such as ours to ignore potential new treatments. Thousands and
thousands of compounds are screened every year to try to find those that
might be the basis of effective treatments. If laetrile or amygdalin had any
therapeutic benefit, drug companies would have developed it into a potential
treatment long ago.